The current tetravalent dengue vaccine TAK-003, from the Japanese laboratory Takeda, is not likely to control the ongoing epidemic, according to the Pan American Health Organization (PAHO). The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results